ACTX-401

N/A

Report date: 2023/10/26 17:03:11

Base Information

Drug NameACTX-401
Drug Alias NameACTX-401ACTX401
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAlcyone Lifesciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlcyone Lifesciences Inc
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy, Spinal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A